6 results
The algorithm below shows how pre-test probability could be combined with various criteria to determine which
course of treatment ... treatment would ... delay therapy by less ... PCR would cause ... is proposed: #Management
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Incidence: 1 to 2 cases ... and sensitive tests ... and cauda equina TREATMENT ... #management #neurology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Epidemiology: • 1-2 cases ... • Weakness: Starts ... #management #treatment ... #neurology
Hearing Loss - Differential Diagnosis Framework

Hearing Loss Types:
• Conductive
• Sensorineural
• Mixed
Presbycusis is the most common type
include a: • Neurologic ... • Outer Ear: ... II ○ Susac’s syndrome ... Labyrinthitis ○ Epstein-Barr ... zoster virus ○ HIV
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
49%) • Weight loss ... 14%), in which case ... DDX: • Epstein-Barr ... Phase: • The short ... ) Treatment:
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
fatiguable chewing, loss ... PCB variants of GBS ... /Edrophonium test ... Gravis #diagnosis #management ... #neurology